TickerFacts.

Femasys Inc (FEMY): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$17.25M
Year ended 2025-12-31
-$17.23M
Trailing 12 months to 2026-06-30
2020-12-31: -$6.25M2021-12-31: -$7.75M2022-12-31: -$11.04M2023-12-31: -$14.02M2024-12-31: -$17.49M2025-12-31: -$17.25M-$17.25M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$17.25Mn/m2026-03-31, From 2025-01-01
2024-12-31-$17.49Mn/m2026-03-31, From 2024-01-01
2023-12-31-$14.02Mn/m2025-03-27, From 2023-01-01
2022-12-31-$11.04Mn/m2024-03-28, From 2022-01-01
2021-12-31-$7.75Mn/m2023-07-24, From 2021-01-01
2020-12-31-$6.25Mn/a2022-03-24, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Femasys Inc (FEMY)2025-12-31-$17.25Mn/m
QHSLab, Inc. (USAQ)2025-12-31$222.0K-37.0%
Vycor Medical Inc (VYCO)2025-12-31$93.4K+85.4%
EBR Systems, Inc. (NONE.)2025-12-31-$45.68Mn/m
Tenon Medical, Inc. (TNON)2025-12-31-$12.53Mn/m
Intelligent Bio Solutions Inc. (INBS)2026-06-30-$11.44Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$8.55Mn/m
RenovoRx, Inc. (RNXT)2025-12-31-$10.51Mn/m
Lucid Diagnostics Inc. (LUCD)2025-12-31-$48.77Mn/m

Compare FEMY, USAQ, VYCO, NONE. side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗